#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypertriglyceridaemia Glycogen storage disease type II Narcolepsy Small cell lung cancer extensive stage Hepato-lenticular degeneration Retinopathy of prematurity Liver transplant rejection Anal fistula Renal disorder Glomerulonephritis Sickle cell disease Factor VIII deficiency Alveolar proteinosis Hypomagnesaemia Plasma cell myeloma More trials…

    Learn about Rare Diseases

    Pleural mesothelioma malignant – Life with Disease Metachromatic leukodystrophy – Treatment Lymphatic malformation – Basic Information Lymphangiosarcoma – Trials in Disease Erdheim-Chester disease – Trials in Disease Usher’s syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information Rett syndrome – Diagnostics Lymphangioma – Life with Disease Advanced systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Nitrite Sodium Iodide (131I) Alendronic Acid Sacituzumab Tirumotecan Indometacin Acetylcysteine Dabrafenib Mk-4830 Iron Sucrose Flortaucipir (18F) Candesartan Thiamine Nitrate SOVATELTIDE Afamelanotide Pyridoxine Testosterone Clopidogrel Hydrogen Sulfate TX000045 Dazukibart Ontasameran More therapies…

    Learn about Your Condition

    Kawasaki's disease Epileptic encephalopathy Choroidal neovascularisation Intestinal ischaemia Meniere's disease Short-bowel syndrome Angiopathy Metastases to lymph nodes CDKL5 deficiency disorder Fibrosarcoma Abdominal wall pain Hypomagnesaemia Essential thrombocythaemia Uterine cancer Pleomorphic leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ceftazidime
    France

  • Study on Botulinum Toxin Type A for Adults with Chronic Pelvic Pain Syndrome (CPPS)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    Italy

  • Study on Zolpidem’s Effects in Patients with Vision Impairments, Disorders of Consciousness, and Neurotypical Volunteers

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ZOLPIDEM TARTRATE
    • Mannitol
    Belgium

  • Study on the Spread of LetibotulinumtoxinA Compared to OnabotulinumtoxinA and AbobotulinumtoxinA in Patients with Moderate to Severe Forehead Wrinkles

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Germany

  • Study on the Effects of Inhaled Nitric Oxide on Heart and Lung Function After Cardiac Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Nitric Oxide
    Spain

  • Study on Filgotinib and Triamcinolone for Newly Diagnosed Rheumatoid Arthritis Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Triamcinolone Acetonide
    The Netherlands
Previous Page
1 … 15 16 17 18 19 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!